116 related articles for article (PubMed ID: 30030980)
21. The PI3K pathway impacts stem gene expression in a set of glioblastoma cell lines.
Martinez E; Vazquez N; Lopez A; Fanniel V; Sanchez L; Marks R; Hinojosa L; Cuello V; Cuevas M; Rodriguez A; Tomson C; Salinas A; Abad M; Holguin M; Garza N; Arenas A; Abraham K; Maldonado L; Rojas V; Basdeo A; Schuenzel E; Persans M; Innis-Whitehouse W; Keniry M
J Cancer Res Clin Oncol; 2020 Mar; 146(3):593-604. PubMed ID: 32030510
[TBL] [Abstract][Full Text] [Related]
22. FOXO transcription factors enforce cell cycle checkpoints and promote survival of hematopoietic cells after DNA damage.
Lei H; Quelle FW
Mol Cancer Res; 2009 Aug; 7(8):1294-303. PubMed ID: 19671690
[TBL] [Abstract][Full Text] [Related]
23. CNK1 is a novel Akt interaction partner that promotes cell proliferation through the Akt-FoxO signalling axis.
Fritz RD; Varga Z; Radziwill G
Oncogene; 2010 Jun; 29(24):3575-82. PubMed ID: 20383191
[TBL] [Abstract][Full Text] [Related]
24. Enabling precision medicine by unravelling disease pathophysiology: quantifying signal transduction pathway activity across cell and tissue types.
van de Stolpe A; Holtzer L; van Ooijen H; Inda MA; Verhaegh W
Sci Rep; 2019 Feb; 9(1):1603. PubMed ID: 30733525
[TBL] [Abstract][Full Text] [Related]
25. Role of FOXO protein's abnormal activation through PI3K/AKT pathway in platinum resistance of ovarian cancer.
Shi YY; Meng XT; Xu YN; Tian XJ
J Obstet Gynaecol Res; 2021 Jun; 47(6):1946-1957. PubMed ID: 33827148
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of flotillin-2 impairs the proliferation of breast cancer cells through modulation of Akt/FOXO signaling.
Xie G; Li J; Chen J; Tang X; Wu S; Liao C
Oncol Rep; 2015 May; 33(5):2285-90. PubMed ID: 25738752
[TBL] [Abstract][Full Text] [Related]
27. The role of Forkhead-box Class O (FoxO) transcription factors in cancer: a target for the management of cancer.
Reagan-Shaw S; Ahmad N
Toxicol Appl Pharmacol; 2007 Nov; 224(3):360-8. PubMed ID: 17275054
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional Activity of FOXO Transcription Factors Measured by Luciferase Assays.
Ávila-Flores A; Arranz-Nicolás J; Mérida I
Methods Mol Biol; 2019; 1890():91-102. PubMed ID: 30414147
[TBL] [Abstract][Full Text] [Related]
29. Depletion of PI3K p85alpha induces cell cycle arrest and apoptosis in colorectal cancer cells.
Sun Y; Zhao S; Tian H; Xie X; Xiao F; Li K; Song Y
Oncol Rep; 2009 Dec; 22(6):1435-41. PubMed ID: 19885597
[TBL] [Abstract][Full Text] [Related]
30. FOXO factors and breast cancer: outfoxing endocrine resistance.
Bullock M
Endocr Relat Cancer; 2016 Feb; 23(2):R113-30. PubMed ID: 26612860
[TBL] [Abstract][Full Text] [Related]
31. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
Li A; Wang J; Wu M; Zhang X; Zhang H
Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of FOXO3a by PI3K/Akt pathway in HK-2 renal proximal tubular epithelial cells exposed to cadmium.
Fujiki K; Inamura H; Matsuoka M
Arch Toxicol; 2013 Dec; 87(12):2119-27. PubMed ID: 23673518
[TBL] [Abstract][Full Text] [Related]
33. Foxo-dependent Par-4 Upregulation Prevents Long-term Survival of Residual Cells Following PI3K-Akt Inhibition.
Damrauer JS; Phelps SN; Amuchastegui K; Lupo R; Mabe NW; Walens A; Kroger BR; Alvarez JV
Mol Cancer Res; 2018 Apr; 16(4):599-609. PubMed ID: 29330285
[TBL] [Abstract][Full Text] [Related]
34. Reciprocal control of Forkhead box O 3a and c-Myc via the phosphatidylinositol 3-kinase pathway coordinately regulates p27Kip1 levels.
Chandramohan V; Jeay S; Pianetti S; Sonenshein GE
J Immunol; 2004 May; 172(9):5522-7. PubMed ID: 15100294
[TBL] [Abstract][Full Text] [Related]
35. FOXO3a is a major target of inactivation by PI3K/AKT signaling in aggressive neuroblastoma.
Santo EE; Stroeken P; Sluis PV; Koster J; Versteeg R; Westerhout EM
Cancer Res; 2013 Apr; 73(7):2189-98. PubMed ID: 23378341
[TBL] [Abstract][Full Text] [Related]
36. FoxO proteins: regulation and molecular targets in liver cancer.
Carbajo-Pescador S; Mauriz JL; García-Palomo A; González-Gallego J
Curr Med Chem; 2014 Apr; 21(10):1231-46. PubMed ID: 24372208
[TBL] [Abstract][Full Text] [Related]
37. Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt.
Yamagata K; Daitoku H; Takahashi Y; Namiki K; Hisatake K; Kako K; Mukai H; Kasuya Y; Fukamizu A
Mol Cell; 2008 Oct; 32(2):221-31. PubMed ID: 18951090
[TBL] [Abstract][Full Text] [Related]
38. PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas.
Nozhat Z; Hedayati M
Mol Diagn Ther; 2016 Feb; 20(1):13-26. PubMed ID: 26597586
[TBL] [Abstract][Full Text] [Related]
39. Chemical genetic analysis of FOXO nuclear-cytoplasmic shuttling by using image-based cell screening.
Zanella F; Rosado A; García B; Carnero A; Link W
Chembiochem; 2008 Sep; 9(14):2229-37. PubMed ID: 18756565
[TBL] [Abstract][Full Text] [Related]
40. Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway.
Guo S; Sonenshein GE
Mol Cell Biol; 2004 Oct; 24(19):8681-90. PubMed ID: 15367686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
